The Comparison of Therapeutic Efficacy Between Dabigatran Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation
H Li, L Zhang, M Xia, C Zhang… - Clinical and Applied …, 2021 - journals.sagepub.com
Background Novel oral anticoagulants and warfarin are widely used for stroke prevention in
patients with atrial fibrillation. The anticoagulation status of patients receiving warfarin or …
patients with atrial fibrillation. The anticoagulation status of patients receiving warfarin or …
Stroke prevention in patients with atrial fibrillation: focus on new oral anticoagulants
PP Toth - Postgraduate medicine, 2013 - Taylor & Francis
Patients with atrial fibrillation are at an increased risk for stroke. Anticoagulation therapy has
been shown to significantly reduce the risk for stroke in these patients. Warfarin therapy is …
been shown to significantly reduce the risk for stroke in these patients. Warfarin therapy is …
A single institution's experience with using dabigatran, rivaroxaban and warfarin for prevention of thromboembolism in atrial fibrillation
LX Chan, YM Wong, PL Chia… - … of Singapore Healthcare, 2018 - journals.sagepub.com
Background: Although non-vitamin K antagonist oral anticoagulants (NOACs) are approved
for stroke prevention in atrial fibrillation (AF) patients, their use in the local clinical setting has …
for stroke prevention in atrial fibrillation (AF) patients, their use in the local clinical setting has …
[HTML][HTML] Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis
PK Bundhun, MZS Soogund, AR Teeluck… - BMC Cardiovascular …, 2017 - Springer
Background Warfarin is commonly used as a secondary prevention of stroke in patients with
atrial fibrillation (AF). However, limitations have been observed even with the use of this …
atrial fibrillation (AF). However, limitations have been observed even with the use of this …
New oral anticoagulants for stroke prevention in atrial fibrillation: more choices bring more challenges
PA Howard - Hospital pharmacy, 2013 - journals.sagepub.com
For patients with atrial fibrillation, anticoagulant therapy is essential to reduce the risk of
ischemic stroke that is associated with this arrhythmia. Historically, warfarin has been the …
ischemic stroke that is associated with this arrhythmia. Historically, warfarin has been the …
Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation
S Uchiyama, S Ibayashi, M Matsumoto, T Nagao… - Journal of Stroke and …, 2012 - Elsevier
Stroke is a major health problem worldwide, and is often fatal or associated with poor long-
term outcomes. Atrial fibrillation (AF) is responsible for up to 20% of all strokes; and the risk …
term outcomes. Atrial fibrillation (AF) is responsible for up to 20% of all strokes; and the risk …
Cost-effectiveness of dabigatran and rivaroxaban compared with warfarin for stroke prevention in patients with atrial fibrillation
Purpose This study aimed to evaluate the cost-effectiveness of dabigatran and rivaroxaban
compared with warfarin for the prevention of stroke in patients with atrial fibrillation (AF) in …
compared with warfarin for the prevention of stroke in patients with atrial fibrillation (AF) in …
Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation
S Schneeweiss, JJ Gagne, AR Patrick… - … Quality and Outcomes, 2012 - Am Heart Assoc
Background—Dabigatran, an oral thrombin inhibitor, and rivaroxaban and apixaban, oral
factor Xa inhibitors, have been found to be safe and effective in reducing stroke risk in …
factor Xa inhibitors, have been found to be safe and effective in reducing stroke risk in …
Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of …
Z Hijazi, SH Hohnloser, J Oldgren, U Andersson… - Circulation, 2014 - Am Heart Assoc
Background—Renal impairment increases the risk of stroke and bleeding in patients with
atrial fibrillation. In the Randomized Evaluation of Long-Term Anticoagulant Therapy (RELY) …
atrial fibrillation. In the Randomized Evaluation of Long-Term Anticoagulant Therapy (RELY) …
Is dabigatran as effective as warfarin on cardiac thrombus in a patient with atrial Fibrillation? A challenging question
Atrial fibrillation (AF) is an important risk factor for cardioembolic stroke. Warfarin is an
effective treatment in reducing the risk of cardioembolic stroke in patients with AF. New …
effective treatment in reducing the risk of cardioembolic stroke in patients with AF. New …
相关搜索
- atrial fibrillation stroke prevention
- atrial fibrillation dabigatran in patients
- therapeutic efficacy warfarin in patients
- atrial fibrillation oral anticoagulation
- bleeding outcomes dabigatran in patients
- atrial fibrillation cardiac thrombus
- atrial fibrillation old concerns
- atrial fibrillation bleeding outcomes
- atrial fibrillation cost effectiveness
- meta analysis dabigatran in patients
- atrial fibrillation meta analysis
- atrial fibrillation warfarin for prevention
- atrial fibrillation rivaroxaban and dabigatran
- atrial fibrillation prevention of thromboembolism